Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Mali Reports Two New Ebola Deaths in Capital

November 12, 2014 9:25 am | by Baba Ahmed - Associated Press | News | Comments

Malian authorities reported two new deaths from Ebola that are not believed to be linked to the nation's only other known case. Read more...                    

TOPICS:

Discovery Opens Up Possibility of Slowing Cancer Spread

November 12, 2014 8:59 am | News | Comments

Researchers found a potential candidate that can inhibit the spread of cancer cells throughout the body. Read more...                        

TOPICS:

Study Identifying Tumor Cell Origin May Help Develop Therapies

November 11, 2014 1:12 pm | News | Comments

UT Southwestern Medical Center researchers have determined the specific type of cell that gives rise to large, disfiguring tumors called plexiform neurofibromas, a finding that could lead to new therapies for preventing growth of these tumors. Read more...

TOPICS:
Advertisement

New Drug Could Make Vaccines More Effective in Elderly

November 11, 2014 1:01 pm | News | Comments

Oxford University scientists have developed a new method of boosting the ageing immune system using a naturally occurring chemical compound. Read more...                                      

TOPICS:

Large-scale Study Raises Hopes for Development of E. Coli Vaccine

November 11, 2014 12:55 pm | News | Comments

The largest ever study of the bacterium enterotoxigenic Escherichia coli (ETEC) has raised hopes that a global vaccine can be developed.  Read more...                                   

TOPICS:

RA Drugs May Promote Vascular Health

November 11, 2014 12:49 pm | News | Comments

HemoShear, a discovery stage biotechnology company, and Janssen will report data showing that a subset of compounds used to treat RA also suppress inflammation and have the potential to promote vascular health. Read more...

TOPICS:

Birth Defects Risk Low for Women Taking Antiretrovirals

November 11, 2014 12:42 pm | News | Comments

Among pregnant women infected with HIV, the use of antiretroviral (ARV) medications early in pregnancy to treat their HIV or to prevent mother-to-child transmission of HIV does not appear to increase the risk of birth defects in their infants. Read more...

Catalyst Advance Has Possibilities for Drug Development

November 11, 2014 12:23 pm | News | Comments

Chemists at The Scripps Research Institute (TSRI) and the Shanghai Institute of Organic Chemistry have described a method for creating and modifying organic compounds that overcomes a major limitation of previous methods. Read more...

TOPICS:
Advertisement

Fighting HIV with Stem Cells and Cutting-edge Genetics

November 11, 2014 10:51 am | by Cynthia Fox, Science Editor | Articles | Comments

“Berlin Patient” Timothy Brown was cured of HIV after he received stem cells from a patient naturally immune to the disease. His story inspired two companies to try and recreate that natural immunity in HIV patients using stem cells and two (then-new) gene-editing techniques. Read more...

TOPICS:

OSU Professor Helps Develop Promising Ebola Drug

November 11, 2014 10:39 am | News | Comments

As the Ebola crisis in Africa continues and concern ramps up in the United States, a pharmaceutical company with a Corvallis connection is ready to respond with a limited amount of a potentially promising new drug. Read more...

TOPICS:

FDA Accepts Amgen's BLA for Cholesterol-Lowering Drug

November 11, 2014 10:27 am | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's Biologics License Application (BLA) for evolocumab for the treatment of high cholesterol. Read more...

TOPICS:

New Research Venture Aims to Lower Cost of Meds

November 11, 2014 10:22 am | News | Comments

Bath is the first institution outside the United States to receive funding from the US Food & Drugs Administration (FDA), for a major new research collaboration that will strive to open up the pharmaceutical drugs market and enable the design of better and cheaper medicines. Read more...

TOPICS:

Google, CEO Donate to Ebola Fight

November 11, 2014 10:16 am | News | Comments

Google is launching a campaign to help fight Ebola by contributing $2 for every dollar people donate to a slew of nonprofits such as Save the Children and the Doctors Without Borders. Read more...

TOPICS:

Gilead's Hep C Drug Gets Positive Results

November 11, 2014 10:09 am | News | Comments

Gilead Sciences Inc. announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options. Read more...

TOPICS:

New Ebola Treatment Unit Opens in Liberia

November 10, 2014 3:07 pm | by Jonathan Paye-Layleh - Associated Press | News | Comments

The United States opened the first of 17 Ebola treatment units it is building in Liberia. Read more...                           

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading